Literature DB >> 29680463

A Novel Regulator of Type II Diabetes: MicroRNA-143.

Biao Li1, Jingjing Fan2, Ning Chen3.   

Abstract

MiR-143 is an miRNA with the function of specifically inhibiting the insulin-AKT pathway via the downregulation of oxysterol-binding protein-related protein 8 (ORP8), thus resulting in the inhibition of AKT phosphorylation, insulin tolerance, and final development of type II diabetes mellitus (T2DM). Aerobic exercise can prevent T2DM by downregulating miR-143. However, the underlying mechanisms for exercise-induced change of miR-143 remain unclear. In the present study, we will summarize the involvement of miR-143 in regulating the development of T2DM and the underlying mechanisms for potential diagnosis, prevention, and treatments, including exercise intervention for T2DM by targeting miR-143.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ORP8; T2DM; exercise intervention; insulin resistance; miR-143

Mesh:

Substances:

Year:  2018        PMID: 29680463     DOI: 10.1016/j.tem.2018.03.019

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  18 in total

1.  The Yin and Yang function of microRNAs in insulin signalling and cancer.

Authors:  Juanhong Liu; Feng Liu
Journal:  RNA Biol       Date:  2020-08-13       Impact factor: 4.652

2.  Oxysterol-binding protein-like 2 contributes to the developmental progression of preadipocytes by binding to β-catenin.

Authors:  Tianming Wang; Tianyu Zhang; Youzhi Tang; Hongshun Wang; Qinjun Wei; Yajie Lu; Jun Yao; Yuan Qu; Xin Cao
Journal:  Cell Death Discov       Date:  2021-05-17

3.  Maternal low-protein diet on the last week of pregnancy contributes to insulin resistance and β-cell dysfunction in the mouse offspring.

Authors:  Emilyn U Alejandro; Seokwon Jo; Brian Akhaphong; Pau Romaguera Llacer; Maya Gianchandani; Brigid Gregg; Sebastian D Parlee; Ormond A MacDougald; Ernesto Bernal-Mizrachi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-09-02       Impact factor: 3.210

Review 4.  Interactions Among lncRNAs/circRNAs, miRNAs, and mRNAs in Neuropathic Pain.

Authors:  Ge Song; Zheng Yang; Jiabao Guo; Yili Zheng; Xuan Su; Xueqiang Wang
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

Review 5.  ORP5 and ORP8: Sterol Sensors and Phospholipid Transfer Proteins at Membrane Contact Sites?

Authors:  Nina Criado Santos; Vladimir Girik; Paula Nunes-Hasler
Journal:  Biomolecules       Date:  2020-06-18

6.  Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Miguel A Miranda-Román; Yasmarie Santana-Rivera; Fatma Valiyeva; Mónica Rivera-Díaz; María J Marcos-Martínez; Pablo E Vivas-Mejía
Journal:  Cancers (Basel)       Date:  2018-10-12       Impact factor: 6.639

Review 7.  Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies.

Authors:  Ruiling Chen; Gangyang Wang; Ying Zheng; Yingqi Hua; Zhengdong Cai
Journal:  J Cell Mol Med       Date:  2019-02-05       Impact factor: 5.310

Review 8.  Mapping Research in the Obesity, Adipose Tissue, and MicroRNA Field: A Bibliometric Analysis.

Authors:  João Manoel Alves; Ramon Handerson Gomes Teles; Camila do Valle Gomes Gatto; Vitor Rosetto Muñoz; Márcia Regina Cominetti; Ana Cláudia Garcia de Oliveira Duarte
Journal:  Cells       Date:  2019-12-06       Impact factor: 6.600

Review 9.  Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity.

Authors:  Alex Cleber Improta Caria; Carolina Kymie Vasques Nonaka; Ciro Silveira Pereira; Milena Botelho Pereira Soares; Simone Garcia Macambira; Bruno Solano de Freitas Souza
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

Review 10.  Major miRNA Involved in Insulin Secretion and Production in Beta-Cells.

Authors:  Mohsen Aghaei; Ali Khodadadian; Karimi-Nazari Elham; Majid Nazari; Emad Babakhanzadeh
Journal:  Int J Gen Med       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.